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Abstract
Background: The structural maintenance of chromosome 3 (SMC3) protein is a constituent of a
number of nuclear multimeric protein complexes that are involved in DNA recombination and
repair in addition to chromosomal segregation. Overexpression of SMC3 activates a tumorigenic
cascade through which mammalian cells acquire a transformed phenotype. This has led us to
examine in depth how SMC3 level affects cell growth and genomic stability. In this paper the effect
of SMC3 knockdown has been investigated.
Results: Mammalian cells that are SMC3 deficient fail to expand in a clonal population. In order to
shed light on the underlying mechanism, experiments were conducted in zebrafish embryos in
which cell competence to undergo apoptosis is acquired at specific stages of development and
affects tissue morphogenesis. Zebrafish Smc3 is 95% identical to the human protein, is maternally
contributed, and is expressed ubiquitously at all developmental stages. Antisense-mediated loss of
Smc3 function leads to increased apoptosis in Smc3 expressing cells of the developing tail and
notocord causing morphological malformations. The apoptosis and the ensuing phenotype can be
suppressed by injection of a p53-specific MO that blocks the generation of endogenous p53 protein.
Results in human cells constitutively lacking p53 or BAX, confirmed that a p53-dependent pathway
mediates apoptosis in SMC3-deficient cells. A population of aneuploid cells accumulated in zebrafish
embryos following Smc3-knockdown whereas in human cells the transient downregulation of
SMC3 level lead to the generation of cells with amplified centrosome number.
Conclusion: Smc3 is required for normal embryonic development. Its deficiency affects the
morphogenesis of tissues with high mitotic index by triggering an apoptotic cascade involving p53
and the downstream p53 target gene bax. Cells with low SMC3 level display centrosome
abnormalities that can lead to or are the consequence of dysfunctional mitosis and/or aneuploidy.
Collectively the data support the view that SMC3 deficiency affects chromosomal stability leading
to the activation of p53-dependent mitotic checkpoint.
Background
The structural maintenance of chromosome 3 protein
(SMC3) has been first identified as a key component of
the multimeric protein complex cohesin that plays an
essential role during the segregation of sister chromatids
[1-3]. In addition to chromosomal segregation, SMC3 is
also involved in DNA recombination and repair [4]. A
multimeric complex containing BRCA1 in addition to
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damage surveillance pathway [5,6]. Recently SMC3, like
p53 and BRCA1, has been identified as the target of the
serine/threonine kinase Chk2 that plays a critical role in
the DNA damage checkpoint pathway [7]. Given its
involvement in pathways affecting genomic stability,
SMC3 level alteration is likely to have a significant impact
on the cellular genetic integrity. Consistent with this view,
elevated SMC3 level has been detected in a significant (~
60%) fraction of human colon carcinoma and in the
tumoral areas of mice genetically prone to develop polyps
[8,9]. In mammalian cells the ectopic expression of SMC3
triggers their transformation to a growth attachment-inde-
pendent phenotype [8]. Furthermore SMC3 upregulation
affects the expression of members of the ras-rho/GTPase
and CREB oncogenic pathways that are key players in cell
cycle regulation, microtubule dynamics, and in cell differ-
entiation and survival [10].
Pioneering work in yeast mutants have shown that Smc3
deficiency leads to the premature separation of sister chro-
matids [11] and the disruption of the mitotic process.
However key differences exist in the regulation of sister
chromatid cohesion between yeast and higher eukaryotic
cells. In particular the timing of dissociation of the
cohesin complex from chromatin at the onset of anaphase
is different [12,13]. How cells of vertebrates respond to
SMC3 downregulation has not been examined in detail.
Low expression of SMC3 has been detected in rat kidney
epithelial cells transfected with Ha-ras [14], in lung epi-
thelial cells infected with WSN virus [15], and in damaged
axons [16], suggesting that downregulation of SMC3 is
part of the response to oncogenes and stress. Knockdown
of Smc3 in c.elegans affects chromosome segregation dur-
ing mitosis and is embryonically lethal, but the underly-
ing mechanism has not been investigated [17]. Other
studies have shown that interference with the formation
or dissolution of the cohesin complex causes abnormal
mitosis [18]. Knockdown of either the cystein protease
securin or of its substrate separase, two key components of
the machinery that free sister chromatids from the grip of
cohesin at the onset of anaphase, leads to aneuploidy
[19,20]. Since SMC3 is an essential component of the
cohesin complex, its deficiency conceivably affects the
complex formation or its function [21]. The study of the
biology of SMC3 deficiency is however hampered by the
fact that mammalian cells that are SMC3-deficient fail to
develop into a clonal population and are selectively elim-
inated. To examine the mechanism and identify the chain
of events, we have turned to zebrafish (danio rerio), a
developmental model where apoptosis and cell growth
arrest can be easily investigated in the whole organism
[22,23]. Zebrafish utilizes cell cycle arrest and apoptosis
(p53-dependent and independent) to control morpho-
genesis [24]. The ability to initiate cell cycle arrest and
apoptosis is however acquired at different time during
development [24-26] thus offering the opportunity of dis-
criminating the effect of a gene product on each pathways.
We have discovered that in zebrafish SMC3 deficiency
triggers apoptosis in highly proliferative areas such as
those in the developing central nervous system and the
tail. We have furthermore established that the morpho-
logical changes occurring in Smc3-deficient embryos are
secondary to p53-mediated apoptosis that is triggered by
the activation of the mitotic checkpoint.
Results
Cloning and chromosomal mapping of zebrafish smc3
In order to identify and characterize the zebrafish smc3
gene, the coding sequence of the human gene was used to
query the NCBI zebrafish genome and dEST databases.
The alignment of the sequences retrieved enabled to
derive the putative sequence of the zebrafish Smc3 protein
(Genbank BC044408). Smc3 is a polypeptide of 1216
amino acids that is >95% identical to the human protein
(Figure 1A). Data mining of the genomic database
showed that Smc3 is encoded by 23 exons harbored in a
genomic region of 48 kb. In dEST and genomic databases
screens, no other zebrafish genes with higher similarity to
other subclasses of the cohesin family than to Smc3, was
found. Thus, like other vertebrates, including humans,
zebrafish has a single smc3 gene. The zebrafish smc3 locus
is located on chromosome 22 between markers Z14657
and Z66142. Based on the mapping of neighbor genes,
this chromosomal region is synthenic with human chro-
mosome 10q25, i. e. the region harboring the SMC3 gene
(Figure 1B). The analysis of the protein secondary struc-
ture utilizing the COIL algorithms revealed that the con-
formational structure of Smc3 is fully conserved in the
human protein (Figure 1C). In particular the location of
the coiled-coil domains and the breaks in the coiled con-
formation are fully conserved thus corroborating the idea
that these are key structural features that are necessary for
the conserved biological functions of SMC3 [27].
Smc3 is maternally and zygotically derived
The temporal expression pattern of smc3 during zebrafish
development was investigated by semiquantitative RT-
PCR. smc3 transcript was detected in fertilized embryos at
developmental stages prior to the onset of zygotic tran-
scription, indicating that this message is maternally
derived. smc3 transcript level remained elevated until the
end of the segmentation stage (Figure 2A) but decreased
thereafter. The expression of smc1, rad21 and sa2, whose
products together with that of smc3 are components the
cohesin protein complex, was detected in embryos since
the early cell divisions (Figure 2B) thus supporting the
conclusion that a functional cohesin complex is opera-
tional since the very early stages of embryogenesis. smc3
transcript localization in the embryo at different develop-Page 2 of 13
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Cloning and chromosomal mapping of the zebrafish smc3 geneFigure 1
Cloning and chromosomal mapping of the zebrafish smc3 gene. A) The ORF of the zebrafish smc3 gene was assembled by 
aligning the sequences of the EST clones identified through a search of the zebrafish genome and dEST databases using the 
human SMC3 polypeptide sequence as query. Zebrafish smc3 encodes a protein that is >95% identical to the human protein. B) 
The zebrafish smc3 locus is synthenic to the human SMC3 locus. Genes mapping in close proximity to both the smc3 and SMC3 
gene locus are also identified. MXI: max interactor protein 1 (a MYC-binding protein); DUSP5: dual specificity phosophatase 5; 
SHOC2: suppressor of clear homolog (a RAS-binding protein); ADRA2: alpha2A adrenergic receptor. C) Prediction of the pro-
tein coiled-coil domains. The numbers on the abscissa corresponds to the amino acid residues. The probability of the polypep-
tide to assume a coiled coil conformation is plotted on the ordinate axis. The contribution of the gene's exons to the five-
domain structural organization of the protein is illustrated at the bottom of the coiled-coil probability plot.
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hybridization using gene-specific antisense riboprobes
(Figure 2C). Throughout the early development stages up
to 9 hpf a diffuse staining was observed throughout the
blastoderm. At the beginning of the segmentation stage
the staining was detected along the entire dorsal axis. At
24 hpf smc3 expression was higher in the head region and
was weaker in the tail. Staining specificity was assessed
using a sense riboprobe in which case no staining was
observed (data not shown).
Smc3 deficiency causes cell death affecting embryonic 
development
Attempts to generate SMC3-deficient clones of mamma-
lian cells has lead us to believe that mammalian cells tol-
erate a marginal decrease in SMC3 level beyond which
apoptosis is triggered (this lab's unpublished observa-
tions, 2006). To investigate whether SMC3 deficiency has
a similar pro-apoptotic effect in a complex cellular con-
text, zebrafish embryos were utilized as model system.
The components of the p53-dependent apoptotic path-
way of mammalian cells are conserved in the zebrafish
embryo and the pathway is activated at specific times dur-
ing development [22,24]. Apoptotic cells can easily be
identified owing to the optical transparency of the embryo
and since zebrafish utilizes apoptosis to direct morpho-
genesis, the process can be monitored in real time. In
addition techniques have been developed that allow to
modulate the level of any given zebrafish gene product
[28]. To achieve Smc3 knockdown, zebrafish were
injected at the one-to-two cell stage with smc3-targeting
morpholino-modified antisense oligonuclotides (MO) to
block smc3 mRNA translation. In order to assess the effi-
cacy and the specificity of the antisense oligos, MO target-
ing the 5'-UT region of the smc3 gene (smc3-MO) and a 4-
bases mismatch control oligo (smc3-mmMO) were
Expression of zebrafish smc3 during embryogenesisFigure 2
Expression of zebrafish smc3 during embryogenesis. A) Semiquantitative RT-PCR analysis of smc3 transcript level in 
zebrafish embryos at different times during development. ef-1 transcript level, which is expressed throughout development, 
was used as internal control. B) Expression of constituents of the cohesin multimeric protein complex: zebrafish smc1, rad21 
and sa2 transcripts were quantitated as described in panel A. C) Spatio-temporal expression of smc3 mRNA. Whole-mount 
mRNA in-situ hybridization was performed at the indicated developmental stages. Left-to-right: lateral view with the animal 
pole up of embryos at 50% epiboly (6 hpf), at 90% epiboly (9 hpf), at 3-somite stage (12 hpf), and at 24 hpf.Page 4 of 13
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administration of smc3-MO (1–8 ng/embryo) leads to a
dose-dependent knockdown of Smc3 protein in embryos
at 24 hpf as revealed by Western immunoblot analysis of
the whole embryo lysate (Figure 3A). On the other hand,
injection of the control smc3-mmMO (8 ng/embryo) has
no effect. Embryo injected with smc3-MO did not display
significant morphological alteration until somitogenesis
(~ 12 hpf) (Figure 3B). At five-somite stage, necrosis was
however evident in the eye and in the cerebellar region. At
24 hpf, in addition to brain necrosis, the morphants dis-
played an overall reduction of the body length. In partic-
ular the tail region was not properly extend. The tail fin
was absent and the terminal region of the tail was col-
lapsed. In addition the notocord morphology was signifi-
cantly affected since unlike the characteristic tight cell
packaging usually observed at this developmental stage,
cells appeared round and disorganized. The severity of the
morphological changes was a function of the dose of MO
administered (Table 1). A second MO targeting a different
sequence of the 5'-UT region of smc3 induced the same
morphological changes. The smc3 morphants could be
rescued by the ectopic expression of Smc3 by administer-
ing capped smc3 mRNA confirming the specificity of the
biological response observed (Table 1).
Smc3 deficiency activates a p53-dependent pathway
Experiments were performed to examine the cellular
abnormalities underlying the altered morphology of the
affected tissues. When stained in vivo with Acridine
Orange, a membrane-permeable aromatic derivative that
preferentially stains apoptotic cells, 24 hpf Smc3-deficient
embryos displayed intense signal at the outer perimeter of
the tail tip (Figure 4A). By contrast in the untreated
embryos of the same age, apoptosis was confined to the
prospective vent. In previous studies apoptosis in
zebrafish during early development has been shown to be
associated with activation of p53-dependent pathways
[22,29-31]. In order to examine the role of p53 in mediat-
ing cell death in Smc3-deficient embryos, experiments
were conducted in a p53-deficient background. TUNEL
assay performed on the whole embryo allowed to exam-
ine the spatial distribution of apoptotic/necrotic cells at
28 hpf. The results revealed a significant increase in the
number of apoptotic cells in the brain and the tail of
embryos following Smc3 knockdown but not when p53-
MO was co-administered with smc3-MO (Figure 4B). To
investigate downstream p53-dependent transcriptional
responses in the zebrafish, we examined the expression of
p53 target genes such as p21WAF1/CIP1 and cyclin D1, based
on their central role in cell-cycle arrest; bax, for its involve-
ment in the apoptosis pathway; and p53 and mdm2 to
explore the feedback loops downstream of p53 (Figure
4C). In 24 hpf Smc3-deficient embryos semiquantitative
RT-PCR analysis showed that p53 transcript level was ele-
vated approximately two-folds. In addition p53 protein
activity was enhanced as indicated by the two fold
increase in mRNA levels of the target genes mdm2,
p21WAF1/CIP1, and bax. At the same time cyclin D1 expres-
sion was decreased suggesting a cell cycle delay at the G1-
S transition. Conversely in a p53-null background, Smc3
knockdown did not affect the expression of the p53-target
Table 1: Effect of SMC3-deficiency on zebrafish development.
Treatments Embryos no. Apoptotic Phenotype (%)
(A) Uninjected
1 nl Danieau buffer 60 0%
(B) SMC3 Morpholino-antisense
smc3-MO (1 ng) 60 45%
smc3-MO (2 ng) 60 56%
smc3-MO (4 ng) 60 86%
smc3-MO (8 ng) 60 100%
smc3-mmMO (8 ng) 60 5%
(C) zfSMC3 rescue
smc3-MO (4 ng)/smc3 mRNA (250 pg) 60 15%
(D) p53 Morpholino-antisense rescue
p53-MO (4 ng) 60 0%
smc3-MO (4 ng)/p53-MO (4 ng) 60 0%
Embryos at 1–2 cell stage were injected in the yolk with 1–3 nl of MO or mRNA to achieve the indicated dose. Each injection session consisted of 
2–3 treatment groups of 30 embryos each and several experiments were performed to reach the sample size indicated. Embryos serving as the 
untreated group were injected with 1 nl of Danieau buffer. Embryos receiving a dual treatment, were first received smc3-MO and after 
randomization, half was injected with p53-MO or smc3-RNA. At 6 hpf the unfertilized eggs were removed and the developing embryos analyzed at 
15 hpf. Embryos showing necrosis in the head were classified as apoptotic.Page 5 of 13
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p53 is required for apoptosis in SMC3-deficient mamma-
lian cells. In these experiments somatic human cells con-
stitutively lacking either p53 or BAX and their wild type
parental cell lines, were utilized. To achieve a status of
SMC3 deficiency cells were transfected with SMC3-spe-
cific siRNA oligonucleotides and harvested 72 h later.
Western immunoblot analysis showed that SMC3 protein
level in the transfected cells had been decreased by 70% or
more (Figure 5A). Interestingly the knockdown of SMC3
had virtually no effect on the level of the SMC1 (see Addi-
tional Figure 1) further suggesting that the concentration
of the two proteins is regulated independently [10]. In
p53 proficient (wild-type) HCT116 cells, SMC3 deficiency
triggered significant apoptosis as evidenced by FACS anal-
ysis of the cell DNA content (Figure 5B). On the other
hand, SMC3 deficiency failed to trigger apoptosis in
HCT116 cells lacking p53. Further corroborating the idea
that a p53-dependent apoptotic pathway is responsible
for cell death following SMC3 knockdown, cells lacking
BAX, the terminal mediator of the p53-dependent apop-
totic cascade, were refractory to apoptosis after treatment
with SMC3-siRNA.
Smc3-deficiency triggers genomic instability
p53 functions primarily as a transducer of DNA damage
signals in cells of higher eukaryotes. Upon DNA damage
or other cellular stress, p53 becomes activated and
induces either cell cycle arrest to allow DNA repair, or
apoptosis to eliminate cells with elevated carcinogenic
potential. In order to distinguish between these two pos-
sible outcomes, we assessed the number of mitotic cells by
performing embryo whole-mount immunostaining of
phosphohistone H3 (pH3), a marker for cells that have
entered mitosis (Figure 6). Thanks to the embryo trans-
parency pH3-reactive cells could be detected throughout
the animal body. At 24 hpf mitotic cells were encountered
at high frequency in the tail (105 ± 18 pH3-positive cells/
tail, n = 3). Although in lower number than that seen in
the untreated embryos, several mitotic cells were also
detected in the tail of Smc3-deficient embryos (73 ± 12
cells/tail, n = 3), supporting the conclusion that increased
apoptosis as opposed to a block of cell division is mainly
responsible for the morphological alteration in embryos
following Smc3 knockdown. This finding is consistent
with the results of previous studies [24,32] that had con-
cluded that after midgastrula stage, the zebrafish embryos
employs apoptosis, in preference to cell proliferation
arrest, to eliminate cells with damaged genetic content.
Given the role that SMC3 plays during mitosis in all
eukaryotic cells, abnormalities in chromosomal segrega-
tion are expected in SMC3-deficient vertebrate cells. The
presence of abnormal chromosomes would then lead to
the activation of both p53-dependent and independent
mitotic checkpoints triggering the apoptotic cascade
through which cells with aberrant chromosomes content
are eliminated. In order to corroborate this hypothesis we
sought for evidences of abnormal mitosis in SMC3-defi-
cient zebrafish and human cells. During early zebrafish
embryogenesis, cells divide every 30 min for the first 5.4
h [33,34]. It is estimated that upon reaching the end of the
segmentation stage zebrafish somatic cells have under-
Effect of Smc3 knockdown on embryogenesisFigure 3
Effect of Smc3 knockdown on embryogenesis. A) Western immunoblot analysis of Smc3 level in embryos injected at 1–2 
cell stage with increasing doses of smc3-MO or smc3-mmMO. At 24 hpf 10 embryos were dechorionated and the yolk remnant 
removed. After homogenization in 100 µl lysis buffer, proteins were separated on 7.5% SDS-PAGE and Smc3 detected by 
immunoblotting using goat anti-human SMC3 antibody followed by ECL reaction. B) Morphogenesis in normal (a-e) and mor-
phant (f-j) embryos injected with 8 ng of smc3-MO. At the indicated times embryos were collected and their morphology 
examined. Note the presence of necrotic cells in the eye and the cerebellar region of embryos at 15 hpf. At 24 hpf the majority 
of the morphants display head necrosis and a range of tail developmental defects including a reduction of the tail extension, the 
loss of chevron-like structure of the somites and the narrowing or disappearance of the notocord.Page 6 of 13
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that have undergone defective mitosis are efficiently elim-
inated through p53-mediated apoptosis [24,26], if their
number is large some may escape elimination and a pop-
ulation of aneuploid cells may thus become evident. In
agreement with this scenario along with a high propor-
tion of apoptotic/necrotic cells, a significant fraction of
aneuploid cells with larger then normal DNA content
were detected by FACS analysis in Smc3 deficient embryo
(Figure 7A). Unlike the zebrafish embryonic cells, human
cells duplicate at far lower rate and FACS analysis is not
suitable to detect the small number of aneuploid cells
generated after few mitosis. However defects in mitosis
can be identified in mammalian cells before they enter
programmed cell death by monitoring the number of cen-
trosomes. At the onset of mitosis, normal cells contain
two centrosomes that are located at the poles of the
mitotic spindle. On the other hand a larger number of
centrosomes is seen in those cells that have undergone
defective mitosis [35]. Centrosome number abnormalities
may be either the cause or the consequence of abnormal
mitosis [36]. Immunostaining of γ-tubulin – a highly con-
served constituent of this organelle, revealed that the cen-
trosome organization is disrupted in a significant fraction
of human 293 cells with low SMC3 level (Figure 7B). The
analysis performed on 200 cells per group revealed that
one-fifth (43/200) of the SMC3-deficient cells display evi-
dence of multipolar spindles whereas only few (3/200) of
the normal cells display this defect.
Discussion
Cell death is the driving force in the morphogenesis of
developing tissues as well as a major factor in homeostasis
of adult organs and tissues. The zebrafish embryo is a
good model for studying the interplay between genetic
and environmental influences on apoptosis [37]. Devel-
opment is rapid, and embryos remain transparent
throughout most of embryogenesis, simplifying the stag-
ing and analysis of whole-mounts. Before mid-blastula
transition, an "embryonic" type cell cycle is operative,
which is characterized by a rapid alternation between S
and M phases and an apparent lack of checkpoints to
monitor completion of these phases [33]. It has been
hypothesized [38] that embryos acquire a general capabil-
ity for apoptosis as a consequence of passage through the
maternal-to-zygotic transition, that is after the maternal
determinants (mRNAs and proteins) have been exhausted
or degraded and replaced by zygotic determinants. The
acquisition of apoptosis capability allows the embryo to
eliminate defective cells, which were inadvertently gener-
ated during the cleavage phase of development to prevent
their contribution to critical lineages later in develop-
ment. Block of cell growth is an alternative mechanism
during embryogenesis that is activated in response to
p53 pathway activation and cell death following Smc3 knockdownFigure 4
p53 pathway activation and cell death following Smc3 knockdown. A) Acrydine Orange (AO) staining of apoptotic cells. 
Embryos at 1-2-two cell stage were injected with 1 nl of Danieau buffer (untreated group) or with 8 ng/embryo smc3-MO and 
at 24 hpf incubated in E3 medium containing 5 µg/ml of the fluorescent dye. Following 1 h incubation, the embryos were 
washed in PBS and observed under a fluorescence microscope. Note the high level of fluorescence signal at the terminal edge 
of the morphant's tail whereas in the untreated embryo fluorescence is only detected at the prospective vent. B) Morphologi-
cal assessment and TUNEL immunostaining of apoptotic and dead cells in morphants. Embryos were injected at 1–2 cell-stage 
with MO to block translation of either smc3 only or of smc3 and p53, and examined at 28 hpf. C) Semi-quantitative RT-PCR of 
smc3, p53 and a p53-target genes transcript level in untreated embryos and in morphants at 24 hpfPage 7 of 13
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Role of p53 and BAX in SMC3-deficiency mediated apoptosis in human HCT116 cellsFigure 5
Role of p53 and BAX in SMC3-deficiency mediated apoptosis in human HCT116 cells. A) Western immunoblot assay of 
SMC3. p53-null, BAX-null and the matching wild-type parental HCT116 cells were transfected with 50 ng/ml SMC3-siRNA (5'-
AACAGCGGUGGCUUUGC-3') and harvested 72 h later in lysis buffer. Proteins were separated on 7.5% SDS-PAGE. After 
transfer onto a nitrocellulose filter, SMC3 was detected using a goat anti-SMC3 antibody followed by ECL reaction. For nor-
malization of the protein loading, the filters were stripped of the SMC3 immunocomplexes and reacted with anti-human β-
actin antibody. Semiquantitative analysis of the protein level was performed by densitometric scanning of the autoradiographs. 
B) Flow cytometry of the cell DNA content. At 72 h post-transfection, cells were collected by trypsinization and fixed over-
night in 70% ethanol at 4°C. After centrifugation, cells were washed once in PBS and then incubated with propidium iodide/
RNase. Cell DNA fluorescence intensity was analyzed on a Coulter Epic flow cytometer. Results were gated and deconvoluted 
with ModFitLT to determine the fraction of apoptotic cells with < 2 N DNA fluorescence intensity. In the graphs the fraction 
of apoptotic cells is highlighted in black.
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Cell DNA content analysis and chromosomal abnormalities following SMC3 knockdownFigure 7
Cell DNA content analysis and chromosomal abnormalities following SMC3 knockdown. A) Cell cycle FACS analysis of 
zebrafish embryonic cells. Embryos at 1–2 cell stage were injected with 1 nl Danieau buffer (left-hand side) or 4 ng of smc3-MO 
(center) or 4 ng of smc3-MO together with 250 pg smc3 mRNA (right-hand side). Batches of 30 embryos at 24 hpf were incu-
bated in 0.05% trypsin 15 min at 25°C and the cells dissociated by pipetting through a large bore glass pipette. After fixation in 
70% ethanol at 4°C overnight, cells were stained with propidium iodine/RNase, and the DNA cell content analyzed by flow 
cytometry. Gated data were used for analysis. Note the presence of a population of aneuploid (DNA > 4) cells in embryos fol-
lowing Smc3 knockdown. B) Analysis of the centrosome organization in human cells. Human 293 cells were transfected with 
50 ng/ml of SMC3-siRNA and after 24 h plated on a poly-lysine-coated coverslip. Fourty-eight h later the cells were fixed in 4% 
para-formaldehyde, permebilized and then incubated with 1:1000 anti-human γ-tubulin antibody. Following incubation with 
Alexafluor 567-conjugated anti-rabbit IgG (Molecular Probes) and DNA staining with DAPI, the cells were examined under a 
fluorescence/UV microscope and the red (Alexafluor 567) and blue (DAPI) signals combined.
Effect of Smc3 knockdown on the phosphorylation in vivo of histone H3Figure 6
Effect of Smc3 knockdown on the phosphorylation in vivo of histone H3. Embryos at 1-2-two cell stage were injected 
with the vehicle alone or with 8 ng/embryo smc3-MO and analyzed at 24 hpf. Embryos were fixed overnight in 4% para-formal-
dehyde and permeabilized by immersion in -20°C acetone for 10 min. After overnight incubation at 4°C with 1 µg/ml rabbit 
anti-pH3 antibody, the embryos were placed in 1 µg/ml HRP-conjugated goat anti-rabbit IgG solution and the immunocom-
plexes detected by reaction with DAB reagent. The punctuate staining pattern visible in the embryo tails identifies the localiza-
tion of the pH3 antigen and thus of the mitotic cells.
Molecular Cancer 2006, 5:52 http://www.molecular-cancer.com/content/5/1/52DNA damage. This mechanism operates before embryos
become capable of disposing cells through apoptosis [32].
The fact that Smc3-deficient embryos do not display sig-
nificant growth retardation at any stage of development
suggests that cell cycle block is not the preferred mecha-
nism to limit the number of defective cells arising from
defective mitosis. This conclusion is also supported by the
evidence that in smc3 morphants the number of pH3-reac-
tive cells, i. e. of those cells that have entered mitosis, is
not significantly affected. Collectively these data thus sup-
port the conclusion that apoptosis is specifically triggered
when Smc3 level falls. Findings similar to those in the
smc3 morphants have been recently reported in the
crash&burn (crb) zebrafish mutant that is genetically lack-
ing functional B-myb [39]. Zebrafish B-myb, like the
human homolog, plays a role in the cell cycle regulation,
particularly at the G2/M transition and the maintenance
of normal ploidy. Metaphase spreads demonstrate that
bmyb mutants contain polyploid and hypertetraploid
cells. As the smc3 morphants, B-myb-null embryos
progress through morphogenesis at normal pace but
develop massive apoptosis in the brain and the tail region.
These findings suggest that in zebrafish mitotic abnormal-
ities are preferentially dealt with through an apoptotic
response. Interestingly haploinsufficiency of bmyb leads to
an increased rate of tumors after carcinogenesis whereas
overexpression data from human tumors suggest that B-
myb acts as an oncogene. This observation and others
have lead to propose that genes controlling the mitotic
checkpoint may affect tumor formation through either
inactivation or overexpression [39,40].
In addition to mounting an apoptotic response, cells that
are SMC3 or B-myb deficient display a further striking
similarity in their centrosomal organization. During mito-
sis, two centrosomes form spindle poles and direct the
formation of bipolar mitotic spindles, which is an essen-
tial event for accurate chromosome segregation into
daughter cells. The presence of more than two centro-
somes severely disturbs mitotic process and cytokinesis
via formation of more than two spindle poles, resulting in
an increased frequency of chromosome segregation errors
[35]. Centrosome amplification is an early event in tumor
formation [41,42]. It occurs in almost all type of cancer
[35] and is considered as a major contributing factor for
chromosome instability in cancer cells leading to aneu-
ploidy [43]. Given that the centrosome organization is
disrupted in a significant fraction of cells with low SMC3
level and that the effect is detectable after transient SMC3
level alteration within the context of few cell duplications,
we speculate that SMC3 may directly affect the centro-
some duplication process. The mechanisms leading to
centrosome amplification are still poorly understood.
High dose of gamma irradiation that induce DNA strand
breaks, induces centrosome amplification but the mecha-
nism through which DNA damage leads to centrosome
amplification remains to be elucidated [44]. Conceivably
the mechanism involves proteins that like SMC3 are
members of the DNA recombination/repair mechanism
and of the mitotic spindle checkpoint. Various proteins
that associate with centrosomes such as pericentrin,
STK15/BTAK/Aurora-A kinase, ATR, BRCA1, BRCA2, have
been shown to influence centrosome duplication in
human cancer [36,45-49]. Of these proteins, BRCA1 has
been shown to bind to SMC3 [5,6]. In addition SMC3
binds to dynactin (this lab's unpublished observation)
and KIF3B kinesin [50], two key components of the cen-
trosome multimeric protein complex. The ability of SMC3
to interact with a number of centrosome proteins hints to
a possible mechanism through which SMC3 may influ-
ence centrosome duplication. Further work is needed to
elucidate the potential role of SMC3 on centrosome
dynamics that may be also indirect and complex.
Conclusion
In this paper we have described the cloning of zebrafish
smc3 and determined that its expression is required for
normal embryonic development. Smc3 deficiency triggers
an apoptotic cascade involving p53 and the downstream
p53 target gene bax. The morphology of tissues such as the
tail that during normal development utilize apoptosis for
remodeling, is drastically altered. The effect of SMC3 defi-
ciency in human cells recapitulates the results in zebrafish
and confirm the involvement of p53. Human SMC3-defi-
cient cells contain an excess number of centrosomes,
whereas a population of aneuploid cells is detected in
smc3 morphants suggesting that SMC3 is a gatekeeper of
genetic stability. We postulate that the deviation of SMC3
from a certain level leads to catastrophic mitoses. The
ensuing aneuploidy in turn activates the p53 apoptotic
pathway leading to the observed morphological changes.
Because aneuploidy is thought to contribute to malignant
transformation and tumor progression, these data suggest




Human kidney embryonic 293 (HEK293) cells were
obtained from ATCC (CRL-1573). p53-null and BAX-null
human colon carcinoma HCT116 cells and the parental
wild-type cell lines were a kind gift of Dr. Volgelstein.
Cells were maintained in DMEM medium supplemented
with 10% fetal calf serum.
Zebrafish breeding
Embryos were obtained from natural mating of wild-type
(Oregon, AB) fish and staged according to criteria previ-
ously outlined [51].Page 10 of 13
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Oligonucleotide sequences matching that of the putative
zebrafish smc3 gene were retrieved by querying zebrafish
dedicated genomic databases using tblastx and the human
SMC3 protein sequence (GenBank NM_005445) as
query. This protocol enabled to identify a number of over-
lapping EST clones belonging to a single major transcript
and whose translated sequence matched that of the
human protein. For cloning of the coding sequence,
mRNA isolated from adult male zebrafish was reverse
transcribed using Sensiscript reverse transcriptase (Qia-
gen) priming with oligo-dT. First strand smc3 cDNA was
then amplified by PCR using pfu DNA polymerase and
primers of sequence 5'-GCATAAACCGCCATGTACAT
TAAA-3' and 5'-TGTGTTTTTCTCTTAGCCGTGAGT-3'. The
amplification reaction was extended 10 min by adding taq
DNA polymerase to generate overhanging termini needed
for insertion of the DNA product into the pcDNA3.1-
TOPO and the pCRII-TOPO vectors. Capped mRNA for
injection in zebrafish embryos was generated using a
mMessage mMachine and T7 RNA polymerase kit
(Ambion).
Embryo microinjection
MOs and mRNAs were injected as 1–3 nl bolus into the
yolk of 1–2 cell embryos. Post-injection (6 hpf) embryos
were sorted, those unfertilized removed and the rest
allowed to grow at 28°C. Morpholino-modified antisense
oligonucleotides (MO) were obtained from Gene Tools.
Those targeting the 5'-UT region of the smc3 gene had
sequence 5'-GTACATGGCGGTTTATGCACAAAAC-3' and
5'-CTCCTCAGAAACCAAATAAATAAAG-3' respectively.
The control 4-base mismatch antisense oligonucleotide
had sequence 5'-GTACtTGGCcGTTTtTGCA gAAAAC-3'.
p53-MO were generated and used as described in the lit-
erature [22]. MO were dissolved in water at a concentra-
tion of 4 mM and further diluted in Danieau buffer (58
mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM
Ca(NO3)2, 5 mM Hepes, pH 7.2) before injection. At
selected times the embryo's morphology was examined
under a stereomicroscope.
In Situ hybridization of zebrafish embryos
Sense and antisense digoxigenin-labeled riboprobes were
generated with T3 or alternatively T7 RNA polymerase
using smc3-pCRII-TOPO as template. Whole embryo in
situ hybridization was performed as previously described
[52].
Semi-quantitative RT-PCR and gene expression profiling
mRNA was extracted from 10 embryos using Tri-Reagent
and reverse transcribed using oligo-dT primers at 37°C for
2 h. An aliquot of the reaction was used as template for
PCR amplification. Reactions were performed in duplicate
and limited to 25 cycles to ensure that the amplification
was not rate-limited by the available reagents. Products
were analyzed on 2% agarose gel. The sets of primers used
is listed in Additional file 2.
Western immunoblot analysis
Embryos were dechorionated and most part of the yolk
removed. After washing in PBS, the embryos were col-
lected by centrifugation and resuspended in 100 µl 0.15 M
Tris-HCl, pH 7.4 buffer containing 0.1% Tween-20. After
homogeneization in an eppendorf tube using a tightly fit-
ted pestel, the embryo debris were removed by centrifuga-
tion and the supernatant applied to a 7.5% SDS-PAGE.
After separation, the proteins were electroblotted to a
nitrocellulose filter and Smc3 detected using goat anti-
human SMC3 antibody (Santa Cruz, 1:1000) following
the manufacturer directions. The immunocomplexes
formed were detected using a Dura kit (Pierce) and the
secondary HPR conjugated rabbit anti-goat IgG antibody
provided in the kit. For Western immunoblotting of
SMC3, 293 human cells were collected in lysis buffer, the
proteins separated on 7.5% SDS-PAGE and immunode-
tected as described for the zebrafish protein. For the nor-
malization of the protein loaded with each sample, SMC3
immunocomplexes-stripped filters were reprobed with
anti-human β-actin monoclonal antibody.
Apoptotic cells detection in embryo whole-mounts
Apoptotic cells were identified in live embryos with Acry-
dine Orange (AO) or in fixed embryos by in situ terminal
deoxynucleotidyl transferase (TdT)-mediated dUTP nick-
end labeling (TUNEL) reaction. For the AO staining,
dechorionated embryos were incubated in 5 µg/ml AO in
fish medium (E3) at 28°C for 30 min and washed three
timed with 30% Danieau solution for 5 min. Before exam-
ination embryos were anaesthetized with 16 mM tricaine.
For the TUNEL assay, embryos were collected and washed
in PBS before fixation in 4% para-formaldehyde, 0.05%
glutaraldehyde, 5 mM EGTA, 5 mM MgSO4 (PGEM solu-
tion) for 1 hr at 25°C. To facilitate reagent penetration,
after washing in PBS, embryos were dehydrated in serial
dilution of pure methanol at -20°C for 15 min and then
incubated 15 min at RT in 0.1% Triton X-100/0.1%
sodium citrate in PBS, followed by three rinse in PBS. An
In Situ Cell Death Detection Kit AP (Roche) was used for
the assay. After rinsing, embryos were incubated with
alkaline phosphatase (AP)-conjugated antifluorescein
antibody for 15 min at 37°C and after washing in PBS, the
apoptotic cells were visualized by incubation with NBT/
BCIP (nitro blue tetrazolium chloride/5-Bromo-4-chloro-
3-indolyl-phosphate) reagent. The embryos were then
mounted in 50% glycerol in PBS and photographed under
a light microscope.Page 11 of 13
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Embryos were fixed overnight in 4% para-formaldehyde
in PBS and permeabilized by immersion in -20°C acetone
for 10 min. After washing in PBS, the embryos were placed
for 30 min in Blocking Reagent (Roche) and incubated
overnight at 4°C with 1 µg/ml rabbit anti-pH3 antibody
(Santa Cruz). Immunostaining was performed using
HRP-conjugated goat anti-rabbit IgG (Pierce) followed by
color development in DAB solution. Stained embryos
were mounted in methylcellulose and examined under a
light microscope.
Centrosome analysis
Human embryonic kidney 293 cells were transfected with
50 ng/ml of SMC3-siRNA. Twenty-four h after transfec-
tion the cells were harvested by trypsinization and plated
on poly-lysine-coated coverslip. Forty-eight h later, cells
were washed with PBS, treated with PGEM containing
0.1% Triton-X100 for 1 hr at 25°C, blocked 1 hr in PBS
containing 1% BSA and permeabilized by treatment with
methanol at -20°C for 15 min. The fixed cells were then
incubated with primary mouse IgG anti-γ-tubulin anti-
body (1:1000) (Santa Cruz) in blocking buffer at 4° over-
night. After reaction with Alexafluor 567-conjugated anti-
rabbit IgG (Molecular Probes) and DNA staining with
DAPI, the cells were examined under a fluorescence/UV
microscope. The acquired γ-tubulin (red) and DNA (blue)
signals were superimposed in Photoshop.
Cell cycle analysis
Batches of 30 embryos were washed twice in ice cold PBS
and digested in 5 ml of ice-cold trypsin solution (0.5 µg/
ml trypsin in a solution of 0.14 M NaCl, 5 mM KCl, 5 mM
glucose, 7 mM NaHCO3, 0.7 mM EDTA buffer, pH 7.2)
with trituration through a large bore glass pipette for 10
min at room temperature. Cell suspensions were centri-
fuged at 1000 g for 7 min, resuspendend in 200 µl PBS
and fixed in 2 ml cold 70% ethanol at 4°C overnight. The
fixed cells were collected by centrifugation, washed in PBS
and incubated with propidium iodine (40 µg/ml), and
RNAse (10 µg/ml) for 30 min at room temperature. Cell
DNA content was analyzed on a Coulter Epic flow cytom-
eter. Human cells were harvested by trypsinization and
fixed/stained as described for the zebrafish cells. At the
time of acquisition the width (FL2-W) and area (FL2-A) of
the PI fluorescence was recorded in linear unit. The Mod-
FitLT software was used to deconvolute DNA histograms
according to a four component model which assumes that
S phase cells distribute equally between 2 N and 4 N cells
and apoptotic cells have DNA content less than 2 N.
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